يعرض 1 - 15 نتائج من 15 نتيجة بحث عن '"Mwaura, M."', وقت الاستعلام: 0.37s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المؤلفون: Mwaura, M., Engel, N.

    المصدر: Mwaura , M & Engel , N 2021 , ' Constructing confidence: User perspectives on AlereLAM testing for tuberculosis ' , International Journal of Infectious Diseases , vol. 112 , pp. 237-242 . https://doi.org/10.1016/j.ijid.2021.09.018

  4. 4
  5. 5
    Book

    المؤلفون: Janssen, R., Mwaura, M., Engel, Nora

    المصدر: Janssen , R , Mwaura , M & Engel , N 2021 , Evidence synthesis and analysis : User perspectives on nucleic acid amplification tests for tuberculosis and tuberculosis drug resistance (interview study) . World Health Organization , Geneva . < https://www.who.int/publications/i/item/9789240029415 >

  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المؤلفون: Guma, P.K., Mwaura, M.

    Relation: Guma, P.K. orcid.org/0000-0001-8511-5664 and Mwaura, M. (2021) Infrastructural configurations of mobile telephony in urban Africa: vignettes from Buru Buru, Nairobi. Journal of Eastern African Studies, 15 (4). pp. 527-545. ISSN 1753-1055

  8. 8
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
  12. 12
    Academic Journal

    المؤلفون: Dawe, M S, Pokhariyal, G P, Mwaura, M F

    مصطلحات موضوعية: persistence, mutual funds, NAV

    وصف الملف: application/pdf

    Relation: Dawe, M. S., Pokhariyal, G. P., & Mwaura, M. F. (2014). The Performance Persistence of Equity and Blended Mutual Funds in Kenya. International Journal of Economics and Finance, 6(8), p153.; http://hdl.handle.net/11295/73707

  13. 13
    Academic Journal

    Relation: https://www.documentation.ird.fr/hor/fdi:010056919; oai:ird.fr:fdi:010056919; Fao P., Ky-Zerbo O., Gouem C., Somda P., Hien H., Ouedraogo P. E., Kania D., Sanou A., Kossiwavi I. A., Sanogo B., Ouedraogo M., Siribie I., Valea D., Ouedraogo S., Some R., Rouet F., Rollins N., McFetridge L., Naidu K., Luchters S., Reyners M., Irungu E., Katingima C., Mwaura M., Ouattara G., Mandaliya K., Wambua S., Thiongo M., Nduati R., Kose J., Njagi E., Mwaura P., Newell M. L., Mepham S., Viljoen J., Bland R., Mthethwa L., Bazin B., Rekacewicz C., Taylor A., Flowers N., Thigpen M., Fowler M. G., Jamieson D., Mofenson L. M., Read J. S., Bork Kirsten, Cames Cécile, Cournil Amandine, Claeys P., Temmerman M., Van de Perre P., Becquart Pierre, Foulongne V., Segondy M., de Vincenzi I., Gaillard P., Farley T., Habib N., Landoulsi S. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs Zidovudine/single-dose Nevirapine prophylaxis) : the Kesho Bora randomized controlled trial. 2012, 55 (3), p. 449-460

  14. 14
  15. 15
    Report